Indegene Limited has appointed Mr. Neeraj Bharadwaj as a Non-Executive Independent Director, effective January 25, 2026, for a five-year term, pending shareholder approval. The decision was based on the recommendation of the Nomination and Remuneration Committee. Mr. Bharadwaj has extensive experience in finance, investment management, and strategic leadership. The company also approved allotment under ESOP Plan 2020 and RSU Plan 2020.
New Board Appointment
Indegene Limited’s Board of Directors, following the recommendation of the Nomination and Remuneration Committee, has approved the appointment of Mr. Neeraj Bharadwaj (DIN: 01314963) as a Non-Executive Independent Director. The appointment was made on December 19, 2025.
Term and Approval
Mr. Bharadwaj’s term is for five years, starting January 25, 2026, and concluding on January 24, 2031. This appointment is subject to shareholder approval via postal ballot.
Director’s Profile
Mr. Bharadwaj holds a Bachelor of Science in Economics with a specialization in Finance from the University of Pennsylvania, Philadelphia, and an MBA in Management from Harvard University, Cambridge, Massachusetts. He has significant experience in private equity, investment management, and strategic leadership. His background includes leading large-scale investments across various sectors and holding advisory roles in global organizations.
Additional Approvals
In addition to the director appointment, the Board also approved allotment under ESOP Plan 2020 and RSU Plan 2020.
Source: BSE